RT Journal Article
SR Electronic
T1 Comprehensive Analysis of Mitochondrial DNA Variation in the Taiwan Biobank: Implications for Complex Traits and Population Genetics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.28.24316086
DO 10.1101/2024.10.28.24316086
A1 Chou, Ting-Hsuan
A1 Chien, Pei-Miao
A1 Chen, Pin-Xuan
A1 Lee, Ni-Chung
A1 Wang, Hurng-Yi
A1 Chang, Yi-Cheng
A1 Chen, Pei-Lung
A1 Hsu, Jacob Shu-Jui
YR 2024
UL http://medrxiv.org/content/early/2024/10/29/2024.10.28.24316086.abstract
AB This study presents a comprehensive analysis of mitochondrial DNA (mtDNA) variation in the Taiwan Biobank (TWB), providing insights into the genetic characteristics of the Taiwanese population and the implications of mtDNA in complex traits. We performed mtDNA genotyping on 1,492 individuals using whole-genome sequencing data and imputed mtDNA variants for 101,473 participants from microarray data. Our analysis identified 23 confirmed pathogenic mtDNA variants, with approximately 1 in 180 individuals carrying such variants. Further exploration of mtDNA haplogroups and ancestry revealed no direct correlation between nuclear and mitochondrial genomes, which reflects their distinct inheritance patterns and evolutionary histories. In a mitochondrial genome-wide association study across 86 traits and 306 mtDNA variants, we discovered novel associations between MT-ND2 gene variants and high myopia, as well as 14 mtDNA variants linked to renal function biomarkers. Notably, renal-associated variants clustered into two main groups: ancestral variants of macrohaplogroup M associated with poorer renal function and variants of the B4b sub-haplogroup linked to improved renal function markers. Our findings highlight the importance of population-specific genetic studies, contributing to our understanding of mitochondrial genetics in the Taiwanese population and its implications for health and disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:TWBR11106-05 of Taiwan Biobank gave ethical approval for this work 202108074RINC of National Taiwan University Hospital gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors